Document:

edit_Ex10_14

		

			Exhibit 10.14

		

		
			
		

		
			 
		

		
			December 3, 2019
		

		
			 
		

		
			Michelle Robertson
		

		
			 
		

		
			Re:  Offer of Employment
		

		
			 
		

		
			Dear Michelle,
		

		
			 
		

		
			On behalf of Editas Medicine, Inc. (the “Company”), I am pleased to offer you employment with the Company.  The purpose of this letter is to set forth the terms of your employment with the Company, should you accept our offer.
		

		
			You will be employed to serve on a full-time basis as the Chief Financial Officer,  reporting to the Chief Executive Officer of the Company.  Your base salary will be at the rate of $15,384.62  per bi-weekly pay period (equivalent to an annualized base salary of $400,000.00).  Your effective date of hire as an employee (the “Start Date”) will be  a date mutually agreed upon by you and the Company on or after January 1, 2020.  You shall work out of the Company’s office in Cambridge, Massachusetts and shall travel as required by your job duties.
		

		
			You will receive a one-time sign on bonus of $140,000, less applicable taxes and withholdings, (the “Signing Bonus”), which will be paid to you in the first regular payroll following your commencement of employment with the Company.  Should you decide to leave the Company (other than for Good Reason) or are terminated for Cause, each within the first year of your employment, you will be expected to repay the bonus in full, in accordance with the Company’s Policy as set forth later herein.  All payments are subject to legally required or permitted tax withholdings.  For purposes of this letter agreement, “Cause”  and “Good Reason” shall have the same definitions as set forth in the Company’s Severance Benefits Plan, as amended.
		

		
			Following the end of each fiscal year and subject to the approval of the Company’s Board of Directors (the “Board”), or a duly authorized committee thereof, you will be eligible for a retention and performance bonus, targeted at 40% of your annualized base salary, based on the Company’s performance goals during the applicable fiscal year as determined by the Board (or such committee) in its sole discretion in accordance with certain corporate goals determined by the Board (or such committee) in its sole discretion each year.  You must be an active employee of the Company on the date any bonus is distributed in order to be eligible for and to earn a
		

		
			
		

		
			

		 

		

			 

		

			

					

						 

					

					

						 

				
	

					

						Confidential

					

					

						1

				

		

			 

		

		

			

		

		

		
			bonus award, as it also serves as an incentive to remain employed by the Company, provided that the Company will award and pay any bonus for the prior calendar year on or before March 15th of the next succeeding calendar year.
		

		
			Subject to approval of the Company’s Board of Directors, you may be granted (i) a stock option to purchase 120,000 shares of the Company’s common stock (the “Option”) at an exercise or purchase price equal to the fair market value of the Company’s common stock on the date of grant and (ii) restricted stock units in the amount of 20,000 units (the “RSU”, together with the Option, the “Equity Awards”).  The Equity Awards are being granted pursuant to Nasdaq Listing Rule 5635(c)(4) as an inducement for you to enter into employment with the Company. The Option will vest over four (4) years at the rate of 25% on the first anniversary of the Start Date, and an additional 2.0833% of the original number of shares at the end of each successive month following the first anniversary of the Start Date until the fourth anniversary of such date.  The RSU will vest over four (4) years at the rate of 25% on the first anniversary of the Start Date, and an additional 25% of the original number of RSU’s will vest at the end of each successive anniversary date of your Start Date until the fourth anniversary of such date. The Equity Awards will be brought to the Board of Directors for approval on or after the date you begin employment with the Company.  The Equity Awards will be granted under and subject to the terms of the Company’s 2015 Stock Incentive Plan and evidenced in writing by, and subject to the terms of a stock option agreement and a restricted stock unit agreement, as applicable, thereunder.
		

		
			Should, within the twelve (12) month period following the Start Date, you (a) resign from employment with the Company (other than for Good Reason) or (b) the Company terminates your employment for Cause, you will be expected to repay the Signing Bonus in full, in accordance with the Company’s Policy as set forth below.
		

		
			The Company’s payment of the Signing Bonus is subject to repayment upon termination of your employment, as set forth above.  Repayment required under this letter agreement will be due and payable to the Company within thirty (30) days of your separation from employment with the Company and/or will be deducted from any amounts due to you from the Company, up to the full balance of what is owed to the Company, subject to applicable law.  By signing and returning this offer letter, you agree to repayment of the Signing Bonus as provided for in this letter agreement, and you further agree to execute any documents requested by the Company at any time authorizing the deduction of such amounts from any amounts due to you from the Company.   If the Company does not take such deduction or any such deduction does not fully satisfy the amount of reimbursement due, you agree to repay the remaining unpaid balance to the Company as set forth above.
		

		
			You will be eligible to participate in the Company’s Severance Benefits Plan, a copy of which is enclosed, at the “Other C-Level Officer” level.  Your eligibility under the Severance Benefits Plan is subject to the terms and conditions thereof.
		

		
			You may participate in any and all benefit programs that the Company establishes and makes available to its employees from time to time, provided  you are eligible under (and subject to all
		

		
			
		

		
			

		 

		

			 

		

			

					

						 

					

					

						 

				
	

					

						Confidential

					

					

						2

				

		

			 

		

		

			

		

		

		
			provisions of) the plan documents governing those programs.  Additionally, you will be eligible for paid vacation and holidays in accordance with Company policy.  Please see the enclosed “2020 Benefits Overview” for detailed information on our benefits and related policies, which currently include 11 paid holidays and a flexible time off program.  The benefit programs made available by the Company, and the rules, terms and conditions for participation in such benefit plans, may be changed by the Company at any time without advance notice.
		

		
			You will be required to execute a Non-Solicitation, Non-Competition, Confidentiality and Assignment Agreement in the form attachment as Exhibit A (the “Agreement”), as a condition of employment. You acknowledge that your eligibility for the Sign On Bonus and Equity Awards referenced herein are contingent upon your agreement to the non-competition provisions set forth in the Non-Solicitation, Non-Competition, Confidentiality and Assignment Agreement.  You further acknowledge that such consideration was mutually agreed upon by you and the Company is fair and reasonable in exchange for your compliance with such non-competition obligations.
		

		
			In making this offer, the Company understands, based on representations made by you, that you are not under any obligation to any former employer or any person or entity which would prevent, limit, or impair in any way your acceptance of this offer or employment or the performance by you of your duties as an employee of the Company.  In accepting this offer you represent and warrant the foregoing to be true and correct and that in connection with providing services to the Company you will not (i) use any confidential and/or proprietary information of any third party, including, without limitation, any former employer, and (ii) bring any biological or other materials to the Company. You further acknowledge and agree that the Agreement was provided to you by the earlier of (i) the date we sent you this letter agreement or (ii) ten (10) business days before the commencement of your employment with the Company.
		

		
			You agree to provide to the Company, within three days of your hire date, documentation of your eligibility to work in the United States, as required by the Immigration Reform and Control Act of 1986.  You may need to obtain a work visa in order to be eligible to work in the United States.  If that is the case, your employment with the Company will be conditioned upon your obtaining a work visa in a timely manner as determined by the Company.
		

		
			It is understood that you are an “at-will” employee.  You are not being offered employment for a definite period of time or pursuant to an employment contract, and either you or the Company may terminate the employment relationship at any time and for any reason, with or without cause, or prior notice and without additional compensation to you.
		

		
			This letter agreement and the Agreement referenced above constitute the complete agreement between you and the Company, contain all of the terms of your employment with the Company and supersede any prior agreements, representations or understandings (formal or informal, whether written, oral or implied) between you and the Company.  This letter agreement may not be amended or modified except by an express written agreement signed by both you and a duly authorized officer of the Company.  Although your job duties, title, reporting relationship, compensation and benefits may change from time to time in the Company's sole discretion and provided that the “at-will” nature of your employment may only be changed by a written
		

		
			
		

		
			

		 

		

			 

		

			

					

						 

					

					

						 

				
	

					

						Confidential

					

					

						3

				

		

			 

		

		

			

		

		

		
			agreement signed by you and the Chief Executive Officer, which expressly states the intention to modify the at-will nature of your employment.  Nothing in this letter shall be construed as an agreement, either express or implied, to pay you any compensation or grant you any benefit beyond the end of your employment with the Company, except to the extent you are eligible for post-employment benefits under the Severance Benefit Plan. The resolution of any disputes under this letter will be governed by the laws of the Commonwealth of Massachusetts.
		

		
			As an employee of the Company, you will be required to familiarize yourself and comply with all Company policies and procedures.  Violations of the Company's policies may lead to immediate termination of your employment.  Further, the Company's premises, including all workspaces, furniture, documents and other tangible materials, together with all information technology resources of the Company (including computers, portable devices, data and other electronic files (whether in hard copy or electronic form), and all internet and email communications) are subject to oversight and inspection by the Company at any time.  Company employees shall have no expectation of privacy with regard to any Company premises, materials, resources or information.
		

		
			The Company’s offer of at-will employment is contingent upon your authorization and successful completion of background and/or reference checks.  You will be required to execute authorizations for the Company to obtain consumer reports and/or investigative consumer reports and use them in conducting background checks as a condition to your employment.  The Company may obtain background reports both pre-employment and from time to time during your employment with the Company, as necessary.
		

		
			Please indicate your acceptance of this offer by signing and returning the enclosed copy of this letter, and the Non-Solicitation, Non-Competition, Confidentiality and Assignment Agreement, no later than December 18, 2019.  You may indicate your acceptance of this offer by signing on the appropriate space below and returning a signed, scanned copy along with the Non-Solicitation, Non-Competition, Confidentiality and Assignment Agreement referenced in this letter to Tricia McCall at tricia.mccall@editasmed.com or returning by mail to Editas Medicine, Inc., 11 Hurley Street, Cambridge, MA 02141, Attention: Tricia McCall.
		

		
			Please know that we are truly excited at the prospect of you becoming part of the Editas team and at your leadership helping to build what we hope will be an exceptional organization, one that is both a scientific pioneer and that delivers transformative medicines to many patients.  We believe that you will be a fundamental part of turning that aspiration into reality
		

		
			Very truly yours,
		

		
			/s/ Tricia McCall
		

		
			Tricia McCall
		

		
			Interim Head of HR 
		

		
			Editas Medicine, Inc.
		

		
			
		

		
			

		 

		

			 

		

			

					

						 

					

					

						 

				
	

					

						Confidential

					

					

						4

				

		

			 

		

		

			

		

		

		
			The foregoing correctly sets forth the terms of my employment by Editas Medicine, Inc.  I am not relying on any other representation, except as set forth in this letter.
		

			
					
						/s/ Michelle Robertson

					
					
						    

					
					
						December 27, 2019

				
	
					
						Michelle Robertson

					
					
						 

					
					
						Date

				

		
			 
		

		 

		

			 

		

			

					

						 

					

					

						 

				
	

					

						Confidential

					

					

						5edit_Ex10_15

		
			Exhibit 10.15
		

		
			Editas Medicine, Inc.
		

		
			Inducement Stock Option Agreement
		

		
			1.             Grant of Option.
		

		
			This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [___________] (the “Grant Date”) to [___________] (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein, a total of [___________] shares (the “Shares”) of common stock, $0.0001 par value per share, of the Company (“Common Stock”) at $[_____] per Share.  Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [___________] (the “Final Exercise Date”).
		

		
			The option evidenced by this agreement was granted to the Participant pursuant to the inducement grant exception under Nasdaq Stock Market Rule 5635(c)(4), and not pursuant to the Company’s 2015 Stock Incentive Plan (the “Plan”) or any equity incentive plan of the Company, as an inducement that is material to the Participant’s employment with the Company.
		

		
			It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”).  Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.
		

		
			2.             Vesting Schedule.
		

		
			Except as otherwise provided herein, this option will become exercisable (“vest”) as to 25% of the original number of Shares on one-year anniversary of the Grant Date and as to an additional 2.0833% of the original number of Shares at the end of each successive month following the one-year anniversary of the Grant Date until the fourth anniversary of the Grant Date.
		

		
			The right of exercise shall be cumulative so that to the extent the option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of this option under Section 3 hereof.
		

		
			3.             Exercise of Option.
		

		
			(a)           Form of Exercise.  Each election to exercise this option shall be in writing, signed by the Participant (or such electronic notice as is approved by the Company), and received by the Company at its principal office, accompanied by this agreement and payment in full as follows:
		

		
			(1)           in cash or by check, payable to the order of the Company;
		

		
			
		

		
			

		 

		

		
			(2)           by (i) delivery of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price and any required tax withholding or (ii) delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price and any required tax withholding;
		

		
			(3)           to the extent approved by the Board of Directors of the Company (the “Board”), in its sole discretion, by delivery (either by actual delivery or attestation) of shares of Common Stock owned by the Participant valued at their fair market value per share as determined by (or in a manner approved by) the Board (the “Fair Market Value”), provided (i) such method of payment is then permitted under applicable law, (ii) such Common Stock, if acquired directly from the Company, was owned by the Participant for such minimum period of time, if any, as may be established by the Board in its discretion and (iii) such Common Stock is not subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements;
		

		
			(4)           to the extent approved by the Board, in its sole discretion, by delivery of a notice of “net exercise” to the Company, as a result of which the Participant would receive (i) the number of shares underlying the portion of this being exercised, less (ii) such number of shares as is equal to (A) the aggregate exercise price for the portion of this option being exercised divided by (B) the Fair Market Value on the date of exercise;
		

		
			(5)           to the extent permitted by applicable law or approved by the Board, in its sole discretion, by payment of such other lawful consideration as the Board may determine; or
		

		
			(6)           by any combination of the above permitted forms of payment.
		

		
			The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for any fractional share or for fewer than ten whole shares.
		

		
			(b)           Continuous Relationship with the Company Required.  Except as otherwise provided in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee, officer or a director of, or consultant or advisor to, the Company or any other entity the employees, officers, directors, consultants, or advisors of which are eligible to receive option grants under the Plan (an “Eligible Participant”).
		

		
			(c)           Termination of Relationship with the Company.  If the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after such cessation (but in no event after the Final Exercise Date), provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation.  Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date, violates the restrictive covenants (including, without limitation, the non-competition, non-solicitation, or
		

		
			
		

		
			

		 

		

		
			confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon such violation.
		

		
			(d)           Exercise Period Upon Death or Disability.  If the Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for “cause” as specified in paragraph (e) below, this option shall be exercisable, within the period of one year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), provided that this option shall be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the Final Exercise Date.
		

		
			(e)           Termination for Cause.  If, prior to the Final Exercise Date, the Participant’s employment or other relationship with the Company is terminated by the Company for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment or other relationship. If, prior to the Final Exercise Date, the Participant is given notice by the Company of the termination of his or her employment or other relationship by the Company for Cause, and the effective date of such termination is subsequent to the date of delivery of such notice, the right to exercise this option shall be suspended from the time of the delivery of such notice until the earlier of (i) such time as it is determined or otherwise agreed that the Participant’s employment or other relationship shall not be terminated for Cause as provided in such notice or (ii) the effective date of such termination (in which case the right to exercise this option shall, pursuant to the preceding sentence, terminate upon the effective date of such termination). If the Participant is party to an employment, consulting or severance agreement or plan with the Company that contains a definition of “cause” for termination of employment or other relationship, “Cause” shall have the meaning ascribed to such term in such agreement. Otherwise, “Cause” shall mean willful misconduct by the Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of any employment, consulting, advisory, nondisclosure, non-competition or other similar agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant’s employment or other relationship shall be considered to have been terminated for “Cause” if the Company determines, within 30 days after the Participant’s resignation, that termination for Cause was warranted.
		

		
			4.             Agreement in Connection with Public Offering.
		

		
			The Participant agrees, in connection with an underwritten public offering of the Common Stock pursuant to a registration statement under the Securities Act, (i) not to (a) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any other securities of the Company or (b) enter into any swap or other agreement that transfers, in
		

		
			
		

		
			

		 

		

		
			whole or in part, any of the economic consequences of ownership of shares of Common Stock or other securities of the Company, whether any transaction described in clause (a) or (b) is to be settled by delivery of securities, in cash or otherwise, during the period beginning on the date of the filing of such registration statement with the Securities and Exchange Commission and ending up to 90 days after the date of the final prospectus relating to the offering, and (ii) to execute any agreement reflecting clause (i) above as may be requested by the Company or the managing underwriters at the time of such offering.  The Company may impose stop-transfer instructions with respect to the shares of Common Stock or other securities subject to the foregoing restriction until the end of the “lock-up” period.
		

		
			5.             Withholding.
		

		
			No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option.  The Participant must satisfy all applicable federal, state, and local or other income and employment tax withholding obligations before the Company will deliver stock certificates or otherwise recognize ownership of Common Stock under this option.  The Company may decide to satisfy the withholding obligations through additional withholding on salary or wages.  If the Company elects not to or cannot withhold from other compensation, the Participant must pay the Company the full amount, if any, required for withholding or have a broker tender to the Company cash equal to the withholding obligations. Payment of withholding obligations is due before the Company will issue any shares on exercise of this option or at the same time as payment of the exercise price, unless the Company determines otherwise. If approved by the Board, in its sole discretion, a Participant may satisfy such tax obligations in whole or in part by delivery (either by actual delivery or attestation) of shares of Common Stock underlying this option valued at their Fair Market Value; provided, however, except as otherwise provided by the Board, that the total tax withholding where stock is being used to satisfy such tax obligations cannot exceed the Company’s minimum statutory withholding obligations (based on minimum statutory withholding rates for federal and state tax purposes, including payroll taxes, that are applicable to such supplemental taxable income), except that, to the extent that the Company is able to retain shares of Common Stock having a fair market value (determined by (or in a manner approved by) the Company)  that exceeds the statutory minimum applicable withholding tax without financial accounting implications or the Company is withholding in a jurisdiction that does not have a statutory minimum withholding tax, the Company may retain such number of shares of Common Stock (up to the number of shares having a fair market value equal to the maximum individual statutory rate of tax (determined by (or in a manner approved by) the Company)) as the Company shall determine in its sole discretion to satisfy the tax liability associated with any Award.  Shares used to satisfy tax withholding requirements cannot be subject to any forfeiture, unfulfilled vesting or other similar requirements.
		

		
			6.             Transfer Restrictions; Clawback.
		

		
			This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent
		

		
			
		

		
			

		 

		

		
			and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. In accepting this option, the Participant agrees to be bound by any clawback policy that the Company has adopted or may adopt in the future.
		

		
			7.             Adjustments for Changes in Common Stock and Certain Other Events.
		

		
			(a)           Changes in Capitalization.  In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any dividend or distribution to holders of Common Stock other than an ordinary cash dividend, the number and class of securities and exercise price per share of this option shall be equitably adjusted by the Company in the manner determined by the Board.  Without limiting the generality of the foregoing, in the event the Company effects a split of the Common Stock by means of a stock dividend and the exercise price of and the number of shares subject to this option are adjusted as of the date of the distribution of the dividend (rather than as of the record date for such dividend), then the Participant, if he or she exercises this option between the record date and the distribution date for such stock dividend, shall be entitled to receive, on the distribution date, the stock dividend with respect to the shares of Common Stock acquired upon exercise of this option, notwithstanding the fact that such shares were not outstanding as of the close of business on the record date for such stock dividend.
		

		
			(b)           Reorganization Events.  A “Reorganization Event” shall mean:  (a) any merger or consolidation of the Company with or into another entity as a result of which all of the Common Stock of the Company is converted into or exchanged for the right to receive cash, securities or other property or is cancelled, (b) any transfer or disposition of all of the Common Stock of the Company for cash, securities or other property pursuant to a share exchange or other transaction or (c) any liquidation or dissolution of the Company.  In connection with a Reorganization Event, the Board may take any one or more of the following actions with respect to this option (or any portion thereof) on such terms as the Board determines: (i) provide that this option shall be assumed, or substantially equivalent option shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof), (ii) upon written notice to the Participant, provide that the unvested and/ or unexercised portion of this option will terminate immediately prior to the consummation of such Reorganization Event unless exercised by the Participant within a specified period following the date of such notice, (iii) provide that this option shall become exercisable, realizable, or deliverable, or restrictions applicable to this option shall lapse, in whole or in part prior to or upon such Reorganization Event, (iv) in the event of a Reorganization Event under the terms of which holders of Common Stock will receive upon consummation thereof a cash payment for each share surrendered in the Reorganization Event (the “Acquisition Price”), make or provide for a cash payment to the Participant with respect to this option equal to (A) the number of shares of Common Stock subject to the vested portion of this option (after giving effect to any acceleration of vesting that occurs upon or immediately prior to such Reorganization Event) multiplied by (B) the excess, if any, of (I) the Acquisition Price over (II) the exercise price of this option and any applicable tax withholdings, in exchange for the termination of this option, (v) provide that, in connection with a liquidation or dissolution of the Company, this option shall convert into the right to receive liquidation proceeds (if 
		

		
			
		

		
			

		 

		

		
			applicable, net of the exercise, measurement or purchase price thereof and any applicable tax withholdings) and (vi) any combination of the foregoing.
		

		
			For purposes of clause (i) above, this option shall be considered assumed if, following consummation of the Reorganization Event, this option confers the right to purchase, for each share of Common Stock subject to this option immediately prior to the consummation of the Reorganization Event, the consideration (whether cash, securities or other property) received as a result of the Reorganization Event by holders of Common Stock for each share of Common Stock held immediately prior to the consummation of the Reorganization Event (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock); provided, however, that if the consideration received as a result of the Reorganization Event is not solely common stock of the acquiring or succeeding corporation (or an affiliate thereof), the Company may, with the consent of the acquiring or succeeding corporation, provide for the consideration to be received upon the exercise of this option to consist solely of such number of shares of common stock of the acquiring or succeeding corporation (or an affiliate thereof) that the Board determined to be equivalent in value (as of the date of such determination or another date specified by the Board) to the per share consideration received by holders of outstanding shares of Common Stock as a result of the Reorganization Event.
		

		
			8.             Miscellaneous.
		

		
			(a)           No Right To Employment or Other Status.  The grant of this option shall not be construed as giving the Participant the right to continued employment or any other relationship with the Company.  The Company expressly reserves the right at any time to dismiss or otherwise terminate its relationship with the Participant free from any liability or claim hereunder.
		

		
			(b)           No Rights As Stockholder.  Subject to the provisions of this option, the  Participant shall not have any rights as a stockholder with respect to any shares of Common Stock to be distributed with respect to this option until becoming the record holder of such shares.
		

		
			(c)           Entire Agreement.  This Agreement and the Company’s Severance Benefits Plan, to the extent applicable to Participant, constitute the entire agreement between the parties, and supersede all prior agreements and understandings, relating to the subject matter hereof.
		

		
			(d)           Amendment.  The Board may amend, modify or terminate this Agreement, including but not limited to, substituting another option of the same or a different type and changing the date of exercise or realization.  Notwithstanding the foregoing, the Participant’s consent to such action shall be required unless (i) the Board determines that the action, taking into account any related action, would not materially and adversely affect the Participant, or (ii) the change is permitted under Section 7 of this Agreement.
		

		
			
		

		
			

		 

		

		
			(e)            Acceleration.  The Board may at any time provide that this option shall become immediately exercisable in whole or in part, free of some or all restrictions or conditions, or otherwise realizable in whole or in part, as the case may be.
		

		
			(f)             Conditions on Delivery of Stock.  The Company will not be obligated to deliver any shares of Common Stock pursuant to this Agreement until (i) all conditions of this Agreement have been met to the satisfaction of the Company, (ii) in the opinion of the Company’s counsel, all other legal matters in connection with the issuance and delivery of such shares have been satisfied, including any applicable securities laws and regulations and any applicable stock exchange or stock market rules and regulations, and (iii) the Participant has executed and delivered to the Company such representations or agreements as the Company may consider appropriate to satisfy the requirements of any applicable laws, rules or regulations.
		

		
			(g)             Administration by Board.  The Board will administer this Agreement and may construe and interpret the terms hereof.  The Board may correct any defect, supply any omission or reconcile any inconsistency in this Agreement in the manner and to the extent it shall deem expedient to carry the Agreement into effect and it shall be the sole and final judge of such expediency.  No director or person acting pursuant to the authority delegated by the Board shall be liable for any action or determination relating to or under this Agreement made in good faith.
		

		
			(h)             Appointment of Committees.  To the extent permitted by applicable law, the Board may delegate any or all of its powers hereunder to one or more committees or subcommittees of the Board (a “Committee”).  All references herein to the “Board” shall mean the Board or a Committee to the extent that the Board’s powers or authority hereunder have been delegated to such Committee.
		

		
			(i)               Severability.  The invalidity or unenforceability of any provision hereof shall not affect the validity or enforceability of any other provision hereof, and each such other provision shall be severable and enforceable to the extent permitted by law.
		

		
			(j)              Governing Law.  This Agreement shall be governed by and interpreted in accordance with the laws of the State of Delaware, excluding choice-of-law principles of the law of such state that would require the application of the laws of a jurisdiction other than the State of Delaware.
		

		
			(k)              Counterparts.  This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together will constitute one in the same instrument.
		

		
			
		

		
			

		 

		

		
			The Company has caused this option to be executed by its duly authorized officer.
		

		
			 
		

			
					
						 

					
					
						EDITAS MEDICINE, INC.

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						By:

					
					
						 

				
	
					
						 

					
					
						Name:

					
					
						 

				
	
					
						 

					
					
						Title:

					
					
						 

				

		
			 
		

		
			
		

		
			

		 

		

		
			PARTICIPANT’S ACCEPTANCE
		

		
			The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof.
		

		
			 
		

		
			 
		

			
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						PARTICIPANT:

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						[                          ]

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						Address:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}]]